Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

MCM7 anticorps

MCM7 Reactivité: Humain, Souris WB, IHC (p) Hôte: Souris Monoclonal DCS-141 unconjugated
N° du produit ABIN487308
  • Antigène Voir toutes MCM7 Anticorps
    MCM7 (Minichromosome Maintenance Complex Component 7 (MCM7))
    Reactivité
    • 117
    • 29
    • 23
    • 11
    • 10
    • 9
    • 9
    • 9
    • 4
    • 2
    • 1
    Humain, Souris
    Hôte
    • 81
    • 35
    • 2
    Souris
    Clonalité
    • 77
    • 41
    Monoclonal
    Conjugué
    • 71
    • 6
    • 3
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Cet anticorp MCM7 est non-conjugé
    Application
    • 78
    • 35
    • 32
    • 24
    • 22
    • 19
    • 13
    • 13
    • 12
    • 11
    • 5
    • 5
    • 3
    • 3
    • 2
    • 1
    • 1
    • 1
    • 1
    Western Blotting (WB), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))
    Specificité
    This antibody reacts with MCM7 (90 kDa) on Western blotting.
    Réactivité croisée (Details)
    Species reactivity (tested):Human and Mouse.
    Attributs du produit
    Synonyms: CDC47, MCM2, CDC47 homolog, P1.1-MCM3, minichromosome maintenance complexcomponent 7, DNA replication licensing factor MCM7
    Purification
    Protein-A Sepharose Chromatography.
    Immunogène
    Human recombinant full MCM7. Remarks: Hybridoma was established by fusion of Mouse myeloma cell NS-2 with Balb/cmouse splenocyte.
    Clone
    DCS-141
    Isotype
    IgG1
    Top Product
    Discover our top product MCM7 Anticorps primaire
  • Indications d'application
    Western Blot: 1 μg/mL for chemiluminescence detection system. Positive Controls: HeLa, A-431, Jurkat, C2C12 cells. Immunohistochemistry: 1 μg/mLHeat treatment is necessary for Paraffin Embedded Sections. Microwave oven: 2 times for 10 minutes each in citrate buffer ( pH 6.5). Positive Control: Tonsil. Detailed procedure is provided in Protocols.
    Other applications not tested.
    Optimal dilutions are dependent on conditions and should be determined by the user.
    Protocole
    SDS-PAGE & Western Blotting1) Wash the cells 3 times with PBS and suspend with 10 volume of cold Lysis buffer (50 mMTris-HCl, pH 7. 2, 250 mM NaCl, 0. 1% NP-40, 2 mM EDTA, 10% glycerol) containingappropriate protease inhibitors. Incubate it at 4°C with rotating for 30 minutes, thensonicate briefly (up to 10 seconds). 2) Centrifuge the tube at 12,000 x g for 10 minutes at 4°C and transfer the supernatant toanother tube. Measure the protein concentration of the supernatant and add the Lysisbuffer to make 8 mg/mL solution. 3) Mix the sample with equal volume of Laemmli’s sample buffer. 4) Boil the samples for 2 minutes and centrifuge. Load 10 μL of the sample per lane in a 1mm thick SDS-polyacrylamide gel for electrophoresis. 5) Blot the protein to a polyvinylidene difluoride (PVDF) membrane at 1 mA/cm2 for 1 hourin a semi-dry transfer system. (Transfer Buffer: 25 mM Tris, 190 mM glycine, 20% MeOH). See the manufacture's manual for the transfer procedure. 6) To reduce nonspecific binding, soak the membrane in 10% skimmed milk (in PBS, pH7. 2) for 1 hour at room temperature, or overnight at 4°C. 7) Incubate the membrane with primary antibody diluted with PBS, pH 7. 2 containing 1%skimmed milk as suggested in the APPLICATIONS for 1 hour at room temperature. (Theoptimal antibody concentration will depend on the experimental conditions. 8) Wash the membrane with PBS (5 minutes x 6 times). 9) Incubate the membrane with the 1: 10000 POD-conjugated anti-mouse IgG diluted with1% skimmed milk (in PBS, pH 7. 2) for 1 hour at room temperature. 10) Wash the membrane with PBS (5 minutes x 6 times). 11) Wipe excess buffer from the membrane, then incubate it with appropriatechemiluminescence reagents for 1 minute. Remove extra reagent from the membrane bydabbing with a paper towel, and seal it in plastic wrap. 12) Expose to an X-ray film in a dark room for 5 minutes. Develop the film as usual. Theconditions for exposure and development may vary. Positive Controls for Western blotting: Jurkat, HeLa, A-431, C2C12Immunohistochemical Staining for Paraffin-Embedded Sections: SAB method1) Deparaffinize the sections with Xylene 3 times for 3-5 minutes each. 2) Wash the slides with Ethanol 3 times for 3-5 minutes each. 3) Wash the slides with PBS 3 times for 3-5 minutes each. 4) Heat treatmentHeat treatment by microwave oven: Place the slides put on staining basket in 500 mLbeaker with 500 mL citrate buffer (pH 6. 5). Cover the beaker with plastic wrap, thenprocess the slides 2 times for 10 minutes each at 500 W with microwave oven. Let theslides cool down in the beaker at room temperature for about 40 minutes. 5) Remove the slides from the citrate buffer and cover each section with 3% H2O2 for 10minutes at room temperature to block endogenous peroxidase activity. Wash 3 times inPBS for 5 minutes each. 6) Remove the slides from PBS, wipe gently around each section and cover tissues withProtein Blocking Agent for 5 minutes to block non-specific antibody staining. Do not wash. 7) Tip off the blocking buffer, wipe gently around each section and cover tissues withprimary antibody diluted with PBS containing 1% BSA as suggested in the APPLICATIONS.
    Restrictions
    For Research Use only
  • Concentration
    1.0 mg/mL
    Buffer
    PBS, pH 7.2 containing 50 % Glycerol without preservatives.
    Agent conservateur
    Without preservative
    Stock
    -20 °C
    Stockage commentaire
    Store the antibody undiluted at -20 °C.
    Shelf life: one year from despatch.
    Date de péremption
    12 months
  • Antigène
    MCM7 (Minichromosome Maintenance Complex Component 7 (MCM7))
    Autre désignation
    MCM7 (MCM7 Produits)
    Synonymes
    anticorps CDC47, anticorps MCM2, anticorps P1.1-MCM3, anticorps P1CDC47, anticorps P85MCM, anticorps PNAS146, anticorps MCM7, anticorps AI747533, anticorps Mcmd7, anticorps mCDC47, anticorps chunp6911, anticorps nyz175, anticorps sr:nyz175, anticorps cdc47, anticorps cdc47-2, anticorps mcm7, anticorps xmcm7, anticorps CG4978, anticorps DmMCM7, anticorps DmeMCM7, anticorps Dmel\\CG4978, anticorps McM7, anticorps Mcp-PCR1, anticorps PCR1, anticorps anon-EST:Liang-1.66, anticorps clone 1.66, anticorps minichromosome maintenance complex component 7, anticorps mini-chromosome maintenance complex protein 7, anticorps minichromosome maintenance complex component 2, anticorps minichromosome maintenance complex component 7 L homeolog, anticorps Minichromosome maintenance 7, anticorps minichromosome maintenance complex component 7 S homeolog, anticorps MCM complex subunit Mcm7, anticorps MCM7, anticorps CDC47, anticorps Mcm7, anticorps MCM2, anticorps mcm7, anticorps mcm7.L, anticorps mcm7.S
    Sujet
    MCM7, also known as CDC47, is a member of the MCM (multicopy maintenance) protein family which act as part of the regulatory machinery allowing DNA to replicate only once during S phase. In quiescent cells, human MCM7 mRNA is almost undetectable. Stimulation of cells to enter the cell cycle results in an increase in MCM7 protein during late G1 to S phase, making it a good marker for proliferation. MCM7 proteins are located in nuclei of the proliferative components of normal lymph nodes, bone marrow, epidermis and mucosa, where they exist both free in the nucleoplasm and bound to chromatin. Malignant tumors expressed increased levels of MCM7, suggesting MCM7 may play a role in normal and neoplastic cell growth in vivoSynonyms: CDC47, CDC47 homolog, DNA replication licensing factor MCM7, MCM2, P1.1-MCM3, minichromosome maintenance complex component 7
    ID gène
    4176
    UniProt
    P33993
    Pathways
    Réparation de l'ADN, Mitotic G1-G1/S Phases, DNA Replication, Chromatin Binding, Synthesis of DNA
Vous êtes ici:
Support technique